Published: November 12, 2025 at 2:37 pm
Nanopalm, a DeepTech from Saudi Arabia, is up next.
Founder and CEO Ali AlHasan is explaining how the company develops and manufactures nanoparticles for gene therapy.
It’s focused on treating genetic diseases like sickle cell disease.
The company has already raised $2.1 million.